Risperdal Verdict Reversed
The $1.2 billion verdict for the state of Arkansas against two pharmaceutical companies for billing Medicaid for off-label use of…
The $1.2 billion verdict for the state of Arkansas against two pharmaceutical companies for billing Medicaid for off-label use of…